These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 17218028)

  • 1. The frequency of aspirin resistance and its risk factors in patients with metabolic syndrome.
    Kahraman G; Sahin T; Kilic T; Baytugan NZ; Agacdiken A; Ural E; Ural D; Komsuoglu B
    Int J Cardiol; 2007 Feb; 115(3):391-6. PubMed ID: 17218028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-clinical atherosclerosis evaluated by carotid artery intima-media thickness and the risk factors in children.
    Yang XZ; Liu Y; Mi J; Tang CS; DU JB
    Chin Med J (Engl); 2007 Mar; 120(5):359-62. PubMed ID: 17376303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions.
    Corrado E; Rizzo M; Muratori I; Coppola G; Novo S
    Menopause; 2008; 15(2):240-7. PubMed ID: 17917609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of inflammation and prevalence of vascular disease in patients with metabolic syndrome.
    Novo G; Corrado E; Muratori I; Tantillo R; Bellia A; Galluzzo A; Vitale G; Novo S
    Int Angiol; 2007 Dec; 26(4):312-7. PubMed ID: 18091698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis--a randomized study.
    Hafström I; Rohani M; Deneberg S; Wörnert M; Jogestrand T; Frostegård J
    J Rheumatol; 2007 Sep; 34(9):1810-6. PubMed ID: 17696277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics.
    Longo-Mbenza B; Nkondi Nsenga J; Vangu Ngoma D
    Int J Cardiol; 2007 Oct; 121(3):229-38. PubMed ID: 17368586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of aspirin resistance in patients with metabolic syndrome.
    Cağirci G; Ozdemir O; Geyik B; Cay S; Oztürk S; Aras D; Topaloğlu S
    Turk Kardiyol Dern Ars; 2009 Oct; 37(7):461-6. PubMed ID: 20098039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of dyslipidemias from childhood to adulthood with carotid intima-media thickness, elasticity, and brachial flow-mediated dilatation in adulthood: the Cardiovascular Risk in Young Finns Study.
    Juonala M; Viikari JS; Rönnemaa T; Marniemi J; Jula A; Loo BM; Raitakari OT
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):1012-7. PubMed ID: 18309111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance, metabolic syndrome, and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Bertoni AG; Wong ND; Shea S; Ma S; Liu K; Preethi S; Jacobs DR; Wu C; Saad MF; Szklo M
    Diabetes Care; 2007 Nov; 30(11):2951-6. PubMed ID: 17704348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study.
    Juonala M; Viikari JS; Kähönen M; Solakivi T; Helenius H; Jula A; Marniemi J; Taittonen L; Laitinen T; Nikkari T; Raitakari OT
    J Am Coll Cardiol; 2008 Jul; 52(4):293-9. PubMed ID: 18634985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy.
    Rajaram V; Pandhya S; Patel S; Meyer PM; Goldin M; Feinstein MJ; Neems R; Liebson PR; Fiedler BM; Macioch JE; Feinstein SB
    Am J Cardiol; 2004 Jun; 93(11A):32C-48C. PubMed ID: 15178515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk stratification after coronary artery bypass surgery by a point-of-care test of platelet function.
    Bevilacqua S; Alkodami AA; Volpi E; Cerillo AG; Berti S; Glauber M; Gianetti J
    Ann Thorac Surg; 2009 Feb; 87(2):496-502. PubMed ID: 19161767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome.
    Thoenes M; Oguchi A; Nagamia S; Vaccari CS; Hammoud R; Umpierrez GE; Khan BV
    Int J Clin Pract; 2007 Nov; 61(11):1942-8. PubMed ID: 17935553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of aspirin resistance and its relationship with cardiovascular risk factors and graft function in renal transplant recipients.
    Acikel S; Yildirir A; Aydinalp A; Demirtas K; Bal U; Kaynar G; Ozin B; Karakayali H; Muderrisoglu H; Haberal M
    Transplant Proc; 2008 Dec; 40(10):3485-8. PubMed ID: 19100419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial function and intima-media thickness in hypertensive patients with erectile dysfunction.
    Vlachopoulos C; Aznaouridis K; Ioakeimidis N; Rokkas K; Tsekoura D; Vasiliadou C; Stefanadi E; Askitis A; Stefanadis C
    J Hypertens; 2008 Sep; 26(9):1829-36. PubMed ID: 18698219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial structure and function in young adults with the metabolic syndrome: the Cardiovascular Risk in Young Finns Study.
    Mattsson N; Rönnemaa T; Juonala M; Viikari JS; Jokinen E; Hutri-Kähönen N; Kähönen M; Laitinen T; Raitakari OT
    Eur Heart J; 2008 Mar; 29(6):784-91. PubMed ID: 18084016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness.
    Zanchetti A; Hennig M; Baurecht H; Tang R; Cuspidi C; Carugo S; Mancia G
    J Hypertens; 2007 Dec; 25(12):2463-70. PubMed ID: 17984668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome is not associated with markers of subclinical atherosclerosis, serum adiponectin and endogenous androgen concentrations in Japanese men with Type 2 diabetes.
    Fukui M; Ose H; Kitagawa Y; Kamiuchi K; Nakayama I; Ohta M; Obayashi H; Yamasaki M; Hasegawa G; Yoshikawa T; Nakamura N
    Diabet Med; 2007 Aug; 24(8):864-71. PubMed ID: 17593243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study.
    Hanefeld M; Marx N; Pfützner A; Baurecht W; Lübben G; Karagiannis E; Stier U; Forst T
    J Am Coll Cardiol; 2007 Jan; 49(3):290-7. PubMed ID: 17239709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the new International Diabetes Federation definition of metabolic syndrome improve prediction of coronary artery disease and carotid intima-media thickening?
    Timóteo A; Santos R; Lima S; Mamede A; Fernandes R; Ferreira R
    Rev Port Cardiol; 2009 Feb; 28(2):173-81. PubMed ID: 19438152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.